Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Revolution Medicines stock | $27.3

Learn how to easily invest in Revolution Medicines stock.

Revolution Medicines Inc is a biotechnology business based in the US. Revolution Medicines shares (RVMD) are listed on the NASDAQ and all prices are listed in US Dollars. Revolution Medicines employs 150 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Revolution Medicines

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RVMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Revolution Medicines stock price (NASDAQ: RVMD)

Use our graph to track the performance of RVMD stocks over time.

Revolution Medicines shares at a glance

Information last updated 2021-10-23.
Latest market close$27.30
52-week range$24.38 - $56.18
50-day moving average $29.06
200-day moving average $31.30
Wall St. target price$33.17
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.08

Buy Revolution Medicines shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Revolution Medicines stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Revolution Medicines price performance over time

Historical closes compared with the close of $27.3 from 2021-10-22

1 week (2021-10-18) -2.50%
1 month (2021-09-24) -11.10%
3 months (2021-07-23) -5.67%
6 months (2021-04-23) -33.74%
1 year (2020-10-23) -32.38%
2 years (2019-10-21) N/A
3 years (2018-10-21) N/A
5 years (2016-10-21) N/A

Revolution Medicines financials

Revenue TTM $40.2 million
Gross profit TTM $-89,269,000
Return on assets TTM -14.61%
Return on equity TTM -27.34%
Profit margin 0%
Book value $9.31
Market capitalisation $2 billion

TTM: trailing 12 months

Shorting Revolution Medicines shares

There are currently 10.3 million Revolution Medicines shares held short by investors – that's known as Revolution Medicines's "short interest". This figure is 4.4% up from 9.9 million last month.

There are a few different ways that this level of interest in shorting Revolution Medicines shares can be evaluated.

Revolution Medicines's "short interest ratio" (SIR)

Revolution Medicines's "short interest ratio" (SIR) is the quantity of Revolution Medicines shares currently shorted divided by the average quantity of Revolution Medicines shares traded daily (recently around 482907.12611346). Revolution Medicines's SIR currently stands at 21.33. In other words for every 100,000 Revolution Medicines shares traded daily on the market, roughly 21330 shares are currently held short.

However Revolution Medicines's short interest can also be evaluated against the total number of Revolution Medicines shares, or, against the total number of tradable Revolution Medicines shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Revolution Medicines's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Revolution Medicines shares in existence, roughly 140 shares are currently held short) or 0.2075% of the tradable shares (for every 100,000 tradable Revolution Medicines shares, roughly 208 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Revolution Medicines.

Find out more about how you can short Revolution Medicines stock.

Revolution Medicines share dividends

We're not expecting Revolution Medicines to pay a dividend over the next 12 months.

Revolution Medicines overview

Revolution Medicines, Inc. , a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). Revolution Medicines, Inc.

Frequently asked questions

What percentage of Revolution Medicines is owned by insiders or institutions?
Currently 1.249% of Revolution Medicines shares are held by insiders and 98.832% by institutions.
How many people work for Revolution Medicines?
Latest data suggests 150 work at Revolution Medicines.
When does the fiscal year end for Revolution Medicines?
Revolution Medicines's fiscal year ends in December.
Where is Revolution Medicines based?
Revolution Medicines's address is: 700 Saginaw Drive, Redwood City, CA, United States, 94063
What is Revolution Medicines's ISIN number?
Revolution Medicines's international securities identification number is: US76155X1000
What is Revolution Medicines's CUSIP number?
Revolution Medicines's Committee on Uniform Securities Identification Procedures number is: 76155X100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site